Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
May 25, 2013
Expression of proto-oncogene cFMS protein in lung, breast, and ovarian cancers
Satoko Kakiuchi-Kiyota, Patrick B Lappin, Catherine Heintz, et al.
Lab on a Chip
|
August 31, 2019
Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective
Garrett R Ainslie, Myrtle Davis, Lorna Ewart, et al.
Drug Discovery Today
|
April 28, 2015
Key considerations in the preclinical development of biosimilars
Lynne A Bui, Susan Hurst, Gregory L Finch, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
July 26, 2006
Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species
Timothy M Coskran, Daniel Morton, Frank S Menniti, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
July 9, 2014
Comparative nonclinical assessments of the proposed biosimilar PF-05280014 and trastuzumab (Herceptin(®))
Susan Hurst, Anne M Ryan, Chee-Keng Ng, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
December 17, 2013
Comparison of hepatic transcription profiles of locked ribonucleic acid antisense oligonucleotides: evidence of distinct pathways contributing to non-target mediated toxicity in mice
Satoko Kakiuchi-Kiyota, Petra H Koza-Taylor, Srinivasa R Mantena, et al.
Brain Research
|
September 12, 2003
Immunohistochemical localization of PDE10A in the rat brain
Thomas F Seeger, Brenda Bartlett, Timothy M Coskran, et al.
Toxicologic Pathology
|
March 8, 2014
Comparative nonclinical assessments of the proposed biosimilar PF-05280586 and rituximab (MabThera®)
Anne M Ryan, Sharon A Sokolowski, Chee-Keng Ng, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Applied Immunohistochemistry & Molecular Morphology : AIMM
|
May 25, 2013
Expression of proto-oncogene cFMS protein in lung, breast, and ovarian cancers
Satoko Kakiuchi-Kiyota, Patrick B Lappin, Catherine Heintz, et al.
Lab on a Chip
|
August 31, 2019
Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective
Garrett R Ainslie, Myrtle Davis, Lorna Ewart, et al.
Drug Discovery Today
|
April 28, 2015
Key considerations in the preclinical development of biosimilars
Lynne A Bui, Susan Hurst, Gregory L Finch, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
July 26, 2006
Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species
Timothy M Coskran, Daniel Morton, Frank S Menniti, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
July 9, 2014
Comparative nonclinical assessments of the proposed biosimilar PF-05280014 and trastuzumab (Herceptin(®))
Susan Hurst, Anne M Ryan, Chee-Keng Ng, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
December 17, 2013
Comparison of hepatic transcription profiles of locked ribonucleic acid antisense oligonucleotides: evidence of distinct pathways contributing to non-target mediated toxicity in mice
Satoko Kakiuchi-Kiyota, Petra H Koza-Taylor, Srinivasa R Mantena, et al.
Brain Research
|
September 12, 2003
Immunohistochemical localization of PDE10A in the rat brain
Thomas F Seeger, Brenda Bartlett, Timothy M Coskran, et al.
Toxicologic Pathology
|
March 8, 2014
Comparative nonclinical assessments of the proposed biosimilar PF-05280586 and rituximab (MabThera®)
Anne M Ryan, Sharon A Sokolowski, Chee-Keng Ng, et al.
Page
of 2